GMO-Z.com Trade UK Limited (“Z.com Trade”), part of the Japan-headquartered GMO CLICK Group, officially launched an independenly developed trading platform today. The London-based branch of GMO CLICK will offer forex, indices and commodities on its multi-asset platform.
Z.com Trade now offers a range of platforms including Z.com Trader, its new flagship browser-based platform, MT4, API/FIX with access to the LMAX Exchange and mobile trading apps for iOS and Android.
“We are excited to announce the full launch of Z.com Trade and with the strong foundation of the in-house technology and expertise that we have developed in our home market of Japan, we look forward to connecting with even more traders around the world through our Forex and CFD trading service,” said Hiroyasu Kito, CEO and president of GMO CLICK Holdings Inc., which heads up GMO CLICK Group.
FXPRIMUS Celebrates 10-Year Anniversary with a Grand Gala in Kuala LumpurGo to article >>
Regulated in the UK by the Financial Conduct Authority (FCA), Z.com Trade’s platforms are currently available in both English and Simplified Chinese (the version used in mainland China), and the firm says more languages will be added in the near future. The GMO CLICK Group proclaims it “looks for continued growth in both Europe and Asia,” which explains its venture outside of Japan.
“In addition to our commitment to providing trader-centric technology and the best pricing possible, we aim to offer innovative solutions that make trading both interesting and enjoyable. We have found that this philosophy makes it simple for new traders to interact with global financial markets, while more experienced traders can engage with a professional environment that continues to meet their needs,” Tomitaka Ishimura, CEO of GMO-Z.com Trade UK Limited added.
“Z.com”, one of only four single-character domain names available with the .com top-level domain, is the global brand of the Japan-headquartered GMO Internet Group. The Japanese group acquired the domain name “www.z.com” for a reported ¥800 million ($6.8 million). The price stems from the rarity of single letter domain names, of which there are only four available. The domain name purchase was an important step in GMO’s plan to spearhead its global growth strategy.